Literature DB >> 28530124

Update in Interstitial Lung Disease 2016.

Athol U Wells1, Toby M Maher1,2.   

Abstract

Year:  2017        PMID: 28530124      PMCID: PMC5519972          DOI: 10.1164/rccm.201702-0351UP

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  68 in total

1.  In-Hospital Mortality after Surgical Lung Biopsy for Interstitial Lung Disease in the United States. 2000 to 2011.

Authors:  John P Hutchinson; Andrew W Fogarty; Tricia M McKeever; Richard B Hubbard
Journal:  Am J Respir Crit Care Med       Date:  2016-05-15       Impact factor: 21.405

2.  MUC5B Promoter Variant rs35705950 Affects MUC5B Expression in the Distal Airways in Idiopathic Pulmonary Fibrosis.

Authors:  Yasushi Nakano; Ivana V Yang; Avram D Walts; Alan M Watson; Britney A Helling; Ashley A Fletcher; Abigail R Lara; Marvin I Schwarz; Christopher M Evans; David A Schwartz
Journal:  Am J Respir Crit Care Med       Date:  2016-02-15       Impact factor: 21.405

3.  Interstitial lung abnormalities and reduced exercise capacity.

Authors:  Tracy J Doyle; George R Washko; Isis E Fernandez; Mizuki Nishino; Yuka Okajima; Tsuneo Yamashiro; Miguel J Divo; Bartolome R Celli; Frank C Sciurba; Edwin K Silverman; Hiroto Hatabu; Ivan O Rosas; Gary M Hunninghake
Journal:  Am J Respir Crit Care Med       Date:  2012-01-20       Impact factor: 21.405

4.  Progression of idiopathic pulmonary fibrosis: lessons from asymmetrical disease.

Authors:  Colas Tcherakian; Vincent Cottin; Pierre-Yves Brillet; Olivia Freynet; Nicolas Naggara; Zohra Carton; Jean-François Cordier; Michel Brauner; Dominique Valeyre; Hilario Nunes
Journal:  Thorax       Date:  2010-09-29       Impact factor: 9.139

5.  Plasma Surfactant Protein-D, Matrix Metalloproteinase-7, and Osteopontin Index Distinguishes Idiopathic Pulmonary Fibrosis from Other Idiopathic Interstitial Pneumonias.

Authors:  Eric S White; Meng Xia; Susan Murray; Rachel Dyal; Candace M Flaherty; Kevin R Flaherty; Bethany B Moore; Ling Cheng; Tracy J Doyle; Julian Villalba; Paul F Dellaripa; Ivan O Rosas; Jonathan D Kurtis; Fernando J Martinez
Journal:  Am J Respir Crit Care Med       Date:  2016-11-15       Impact factor: 21.405

6.  MUC5B promoter polymorphism and interstitial lung abnormalities.

Authors:  Gary M Hunninghake; Hiroto Hatabu; Yuka Okajima; Wei Gao; Josée Dupuis; Jeanne C Latourelle; Mizuki Nishino; Tetsuro Araki; Oscar E Zazueta; Sila Kurugol; James C Ross; Raúl San José Estépar; Elissa Murphy; Mark P Steele; James E Loyd; Marvin I Schwarz; Tasha E Fingerlin; Ivan O Rosas; George R Washko; George T O'Connor; David A Schwartz
Journal:  N Engl J Med       Date:  2013-05-21       Impact factor: 91.245

7.  Accuracy and Reliability of Internet Resources for Information on Idiopathic Pulmonary Fibrosis.

Authors:  Jolene H Fisher; Darragh O'Connor; Alana M Flexman; Shane Shapera; Christopher J Ryerson
Journal:  Am J Respir Crit Care Med       Date:  2016-07-15       Impact factor: 21.405

8.  A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.

Authors:  Talmadge E King; Williamson Z Bradford; Socorro Castro-Bernardini; Elizabeth A Fagan; Ian Glaspole; Marilyn K Glassberg; Eduard Gorina; Peter M Hopkins; David Kardatzke; Lisa Lancaster; David J Lederer; Steven D Nathan; Carlos A Pereira; Steven A Sahn; Robert Sussman; Jeffrey J Swigris; Paul W Noble
Journal:  N Engl J Med       Date:  2014-05-18       Impact factor: 91.245

9.  Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis.

Authors:  Tasha E Fingerlin; Elissa Murphy; Weiming Zhang; Anna L Peljto; Kevin K Brown; Mark P Steele; James E Loyd; Gregory P Cosgrove; David Lynch; Steve Groshong; Harold R Collard; Paul J Wolters; Williamson Z Bradford; Karl Kossen; Scott D Seiwert; Roland M du Bois; Christine Kim Garcia; Megan S Devine; Gunnar Gudmundsson; Helgi J Isaksson; Naftali Kaminski; Yingze Zhang; Kevin F Gibson; Lisa H Lancaster; Joy D Cogan; Wendi R Mason; Toby M Maher; Philip L Molyneaux; Athol U Wells; Miriam F Moffatt; Moises Selman; Annie Pardo; Dong Soon Kim; James D Crapo; Barry J Make; Elizabeth A Regan; Dinesha S Walek; Jerry J Daniel; Yoichiro Kamatani; Diana Zelenika; Keith Smith; David McKean; Brent S Pedersen; Janet Talbert; Raven N Kidd; Cheryl R Markin; Kenneth B Beckman; Mark Lathrop; Marvin I Schwarz; David A Schwartz
Journal:  Nat Genet       Date:  2013-04-14       Impact factor: 38.330

10.  Nintedanib in patients with idiopathic pulmonary fibrosis and preserved lung volume.

Authors:  Martin Kolb; Luca Richeldi; Jürgen Behr; Toby M Maher; Wenbo Tang; Susanne Stowasser; Christoph Hallmann; Roland M du Bois
Journal:  Thorax       Date:  2016-09-26       Impact factor: 9.139

View more
  3 in total

1.  The Role of Rho GTPases During Fibroblast Spreading, Migration, and Myofibroblast Differentiation in 3D Synthetic Fibrous Matrices.

Authors:  Daniel L Matera; Alexander T Lee; Harrison L Hiraki; Brendon M Baker
Journal:  Cell Mol Bioeng       Date:  2021-09-02       Impact factor: 3.337

Review 2.  Cell-Based Therapies for Tissue Fibrosis.

Authors:  Rebecca Lim; Sharon D Ricardo; William Sievert
Journal:  Front Pharmacol       Date:  2017-09-22       Impact factor: 5.810

3.  Identification of a Novel HIF-1α-αMβ2 Integrin-NET Axis in Fibrotic Interstitial Lung Disease.

Authors:  Akif A Khawaja; Deborah L W Chong; Jagdeep Sahota; Theresia A Mikolasch; Charis Pericleous; Vera M Ripoll; Helen L Booth; Saif Khan; Manuel Rodriguez-Justo; Ian P Giles; Joanna C Porter
Journal:  Front Immunol       Date:  2020-10-15       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.